As was mentioned yesterday it could be easier to recruit patients in the UK because of the NHS and because geographically the cancer centers being used cover the whole of England.
Thanks I found this paper interesting too
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4976787/
Agreed on both fronts RD.
And it's working for some patients where it wasn't expected to work, which is fantastic.
I wonder if any of the 2 week cohort are first line as Chris did say some might be in the last presentation.